Blog

NeuroPace (NASDAQ:NPCE), a medical technology company known for its brain-responsive neuromodulation device for drug-resistant epilepsy, published its second quarter results on August 12, 2025

Pulse Biosciences (NASDAQ:PLSE), a medical device innovator focused on nanosecond pulsed field ablation (nsPFA) for treating various conditions, released its second-quarter 2025 results on August

Nexgel (NASDAQ:NXGL), a maker of hydrogel-based wound care and beauty products, released its second quarter results for fiscal 2025 on August 12, 2025. The key news from the release was strong

ProKidney (NASDAQ:PROK), a biopharmaceutical company developing cell therapies for chronic kidney disease (CKD), released its second quarter results on August 12, 2025. The main focus of the release

Zevra Therapeutics (NASDAQ:ZVRA), a biopharmaceutical company focused on rare diseases, announced its Q2 2025 financial results on August 12, 2025.

The most notable headline was a sharp

Fractyl Health (NASDAQ:GUTS), a clinical-stage biotech developing interventions for obesity and Type 2 Diabetes (T2D), reported its second quarter 2025 results on August 12, 2025. The period was

Lineage Cell Therapeutics (NYSEMKT:LCTX), a biotechnology company advancing cell-based therapies for serious diseases, released its earnings for the quarter ended June 30, 2025 on August 12, 2025

Citius Oncology (NASDAQ:CTOR), a biopharmaceutical company focused on cancer treatments, released results for its fiscal third quarter on August 12, 2025. The most pivotal news was an upside

Kopin (NASDAQ:KOPN), a technology firm specializing in microdisplays used in defense systems and industrial devices, reported Q2 FY2025 earnings on August 12, 2025. The company reported a sharp

Lululemon (NASDAQ: LULU) was once a market darling. It is now one of the worst-performing stocks of 2025. Shares are off close to 50% so far in 2025 on rising fears of competition and macroeconomic

This year has been an emotional roller coaster for shareholders of Nvidia (NASDAQ: NVDA). Following the news of new tariffs, in combination with intensifying competition in China, the company's

After a brutal pandemic-induced dry dock, the cruise industry has managed to come out not just afloat, but steaming full speed ahead. For investors charting their next investment course, the choice

Back in 1999, a fledgling semiconductor company called Nvidia invented a chipset called the graphics processing unit (GPU) -- a product that, at the time, few people realized they would one day

Stablecoins are hot on Wall Street. From a big-picture perspective, they represent a mixture of technology and finance. But the newness of stablecoins means they aren't tested to the same degree as

Cameco's (NYSE: CCJ) share price has roughly doubled in value over the past year. Much of that gain has taken place since a rally started in April. Can Cameco's shares continue to rocket higher, or

If you follow the market, then you likely know that technology and tech-related stocks have dominated the conversation and fueled the strong returns of the past few years, largely due to excitement

Shares of Toast (NYSE: TOST) dipped despite the cloud-based restaurant management software company reporting strong Q2 results and increasing its guidance. The stock is up about 20% year to date

Explore the exciting world of Adyen (OTC: ADYE.Y) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends

Investors were happy to crank Tencent Music (NYSE: TME) on Tuesday. Following the release of encouraging quarterly results by the China-based company, they sent its U.S.-traded American Depositary

Etoro (NASDAQ: ETOR) stock sank in Tuesday's trading. The company's share price ended the daily session down 8.3% and had been off as much as 9.6% earlier in the session. The sell-offs came despite

Electric utility Vistra (NYSE: VST) demonstrated some impressive power as a stock on Tuesday. The company's shares enjoyed a nearly 5% increase in price on the back of two price target increases

Monday's hangover turned into Tuesday's party for healthcare stock Roivant Sciences (NASDAQ: ROIV). On the back of a modest but meaningful analyst price target hike, investors bid the stock up by

Image source: The Motley Fool.

Tuesday, August 12, 2025 at 5 p.m. ET

Chief Executive Officer — Alessandro Horta

Continue reading

Source Fool.com

Intapp (NASDAQ:INTA) reported fourth quarter fiscal 2025 results on August 12, 2025, highlighting Cloud annual recurring revenue (ARR) grew 29% year over year to $383 million and non-GAAP operating

CoreWeave (NASDAQ:CRWV) reported second quarter 2025 earnings on August 12, 2025, delivering record revenue of $1.2 billion and adjusted operating income of $200 million, with contracted backlog